Your browser doesn't support javascript.
loading
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
von Minckwitz, Gunter; du Bois, Andreas; Schmidt, Marcus; Maass, Nicolai; Cufer, Tanja; de Jongh, Felix E; Maartense, Eduard; Zielinski, Christoph; Kaufmann, Manfred; Bauer, Wolfgang; Baumann, Klaus H; Clemens, Michael R; Duerr, Ralph; Uleer, Christoph; Andersson, Michael; Stein, Robert C; Nekljudova, Valentina; Loibl, Sibylle.
Affiliation
  • von Minckwitz G; GBG Forschungs GmbH, University of Frankfurt, Schleussnerstr 42, Neu-Isenburg, Germany 63263. Gunter.vonMinckwitz@germanbreastgroup.de
J Clin Oncol ; 27(12): 1999-2006, 2009 Apr 20.
Article in En | MEDLINE | ID: mdl-19289619

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2009 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2009 Type: Article